Glioblastoma multiforme (GBM) is a primary malignant brain tumor characterized by a high
grade of malignancy and an extremely unfavorable prognosis. The current efficacy of …

The development of chemoresistance is a major hurdle for the treatment of colorectal cancer
(CRC), which contributes remarkably to the poor clinical prognosis. Nanodrug delivery …

Despite the emergence of cutting-edge therapeutic strategies and tremendous progress in
research, a complete cure of glioma remains elusive. The heterogenous nature of tumor …

Brain, a subtle organ of multifarious nature presents plethora of physiological, metabolic and
bio-chemical convolutions that impede the delivery of biomolecules and thereby resulting in …

Glioblastoma is the most common and most aggressive primary brain cancer in adults.
Standard treatment of glioblastoma consisting of maximal safe resection, adjuvant …

Glioblastoma (GBM) is the most aggressive primary brain tumor with poor prognosis and
high recurrence rate. The presence of the blood–brain barrier (BBB) prevents diagnostic and …

Glioblastoma Multiforme (GBM) is one the most common intracranial tumors discovered by
Burns (1800) and Abernethy (1804) based on gross morphology of the autopsied material …

The clinical translation of new nanoparticle-based therapies for high-grade glioma (HGG)
remains extremely poor. This has partly been due to the lack of suitable preclinical mouse …

Glioblastoma (GBM) has been regarded as one of the most deadly and challenging cancers
to treat with extremely poor prognosis. The limited efficacy of current chemotherapies might …

Simple Summary Glioblastoma (GBM) is the most common form of primary malignant brain
tumor with a devastatingly poor prognosis. Tumor heterogeneity (cellular, molecular and …